140 related articles for article (PubMed ID: 37005275)
1. Can Fractional Exhaled Nitric Oxide (FeNO) Serve as a Clinical Indicator for Patients Hospitalized with Crimean-Congo Hemorrhagic Fever?
Kerget F; Kerget B
Jpn J Infect Dis; 2023 Jul; 76(4):226-232. PubMed ID: 37005275
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the role of serum DcR3 levels in the early clinical prognosis of patients with Crimean-Congo hemorrhagic fever.
Kerget F; Kerget B; Laloglu E
Clin Biochem; 2023 Aug; 118():110574. PubMed ID: 37100109
[TBL] [Abstract][Full Text] [Related]
3. Importance of endothelial dysfunction biomarkers in patients with Crimean-Congo hemorrhagic fever.
Arslan M; Yilmaz G; Mentese A; Yilmaz H; Karahan SC; Koksal I
J Med Virol; 2017 Dec; 89(12):2084-2091. PubMed ID: 28628220
[TBL] [Abstract][Full Text] [Related]
4. [A New Score for Predicting Mortality in Crimean-Congo Hemorrhagic Fever Associating CURB-65 with Bleeding: CURB-65+B].
İnan Sarıkaya R; Karaşahin Ö
Mikrobiyol Bul; 2023 Oct; 57(4):553-567. PubMed ID: 37885385
[TBL] [Abstract][Full Text] [Related]
5. Crimean-Congo hemorrhagic fever in children.
Tezer H; Sucakli IA; Sayli TR; Celikel E; Yakut I; Kara A; Tunc B; Ergonul O
J Clin Virol; 2010 Jul; 48(3):184-6. PubMed ID: 20444644
[TBL] [Abstract][Full Text] [Related]
6. [The Role of Blood Urea Nitrogen and C-Reactive Protein and Their Ratios to Albumin in Predicting Mortality in Crimean-Congo Hemorrhagic Fever].
Karaşahin Ö; İnan Sarıkaya R
Mikrobiyol Bul; 2023 Jul; 57(3):419-431. PubMed ID: 37462305
[TBL] [Abstract][Full Text] [Related]
7. Biosensor-based methods for Crimean-Congo hemorrhagic fever virus detection.
Zandi M; Rasooli A; Soltani S; Teymouri S; Mohammadi S; Abbasi S
J Vector Borne Dis; 2021; 58(4):383-385. PubMed ID: 35381829
[TBL] [Abstract][Full Text] [Related]
8. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever.
Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
Scand J Infect Dis; 2010 May; 42(5):385-8. PubMed ID: 20095935
[TBL] [Abstract][Full Text] [Related]
9. Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana.
Akuffo R; Brandful JA; Zayed A; Adjei A; Watany N; Fahmy NT; Hughes R; Doman B; Voegborlo SV; Aziati D; Pratt D; Awuni JA; Adams N; Dueger E
BMC Infect Dis; 2016 Jul; 16():324. PubMed ID: 27392037
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of seroprevalence and clinical and laboratory findings of patients admitted to health institutions in Gümüşhane with suspicion of Crimean-Congo hemorrhagic fever.
Gürbüz E; Ekici A; Ünlü AH; Yılmaz H
Turk J Med Sci; 2021 Aug; 51(4):1825-1832. PubMed ID: 33754650
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever.
Menteşe A; Yilmaz G; Sümer A; Arslan M; Karahan SC; Köksal I
Int J Infect Dis; 2013 Nov; 17(11):e1042-5. PubMed ID: 23632301
[TBL] [Abstract][Full Text] [Related]
12. Effects of Paraoxonase-1 variants on course of severity and mortality of Crimean-Congo hemorrhagic fever.
Karakus N; Yigit S; Duygu F; Barut S; Rustemoglu A; Basol N
Gene; 2019 Mar; 687():188-192. PubMed ID: 30465883
[TBL] [Abstract][Full Text] [Related]
13. Crimean-Congo hemorrhagic fever: aid of abdominal ultrasonography in prediction of severity.
Ziraman I; Celikbas A; Ergonul O; Degirmenci T; Uyanik SA; Koparal S; Dokuzoguz B
Vector Borne Zoonotic Dis; 2014 Nov; 14(11):817-20. PubMed ID: 25409273
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.
Hekimoğlu HC; Demirci NA
Afr Health Sci; 2014 Dec; 14(4):873-81. PubMed ID: 25834496
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside-Modified mRNA Vaccines Protect IFNAR
Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever.
Akinci E; Bodur H; Sunbul M; Leblebicioglu H
Antiviral Res; 2016 Aug; 132():233-43. PubMed ID: 27378224
[TBL] [Abstract][Full Text] [Related]
17. Hitit Index to distinguish patients with and without Crimean-Congo hemorrhagic fever.
Kayadibi H; Yapar D; Akdogan O; Ulusu NN; Baykam N
Ticks Tick Borne Dis; 2019 Aug; 10(5):1035-1040. PubMed ID: 31160263
[TBL] [Abstract][Full Text] [Related]
18. Relationship of plasma cell-free DNA level with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
Bakir M; Engin A; Kuskucu MA; Bakir S; Gündag O; Midilli K
J Med Virol; 2016 Jul; 88(7):1152-8. PubMed ID: 26680021
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of headache and its relationship with disease severity in patients with Crimean-Congo hemorrhagic fever.
Aksoy D; Barut H; Duygu F; Çevik B; Kurt S; Sümbül O
Agri; 2018 Jan; 30(1):12-17. PubMed ID: 29450871
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Crimean-Congo hemorrhagic fever suspected cases admitted to a secondary care hospital in Kastamonu, Turkey between 2014-2017.
Gozdas HT
Afr Health Sci; 2019 Mar; 19(1):1433-1440. PubMed ID: 31148970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
